SAN LUIS OBISPO, Calif.--(Healthcare Sales & Marketing Network)--FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the inclusion of Dynavisc on the Australian Register of Therapeutic Goods (ARTG). Dynavi...
Devices, Regulatory
FzioMed, Dynavisc, viscoelastic gel, adhesions, Oxiplex, Medishield

Renaissance System to be Installed in Newly-Opened Orthopaedic & Spine Hospital in New Delhi CAESAREA, Israel--(Healthcare Sales & Marketing Network)--Mazor Robotics Ltd. (MZOR.TA), a developer of innovative surgical robots and complementary products, t...
Devices, Neurosurgery, Orthopaedic
Mazor Robotics, Renaissance system, robotic surgery, spine surgery

NASHUA, N.H. & CHICAGO--(Healthcare Sales & Marketing Network)--Booth #303--iCAD, Inc. (ICAD), a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer, today announced that the Company’s Xoft®...
Devices, Surgery, Oncology
iCAD , Xoft Axxent, Electronic Brachytherapy, IORT, brachytherapy, radiotherapy

BOCA RATON, FL--(Healthcare Sales & Marketing Network) - Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today that it is adding to the expertise on its board of directors with the appointment of Lowell Rush as independent director and Chai...
Devices, Neurosurgery, Personnel
Vycor Medical, ViewSite, Surgical Access System

Approval offers a once-daily option as part of a regimen for HIV-1 infected infants as young as three months and weighing at least 3.5 kg “Capsule sprinkle” administration allows dosing in patients who cannot swallow capsules or tablets PRINCETON, N...
Biopharmaceuticals, HIV/AIDS, FDA
Bristol-Myers Squibb, SUSTIVA, efavirenz

SAN DIEGO, May 3, 2013 -- (Healthcare Sales & Marketing Network) -- Ambrx today entered into a collaboration agreement with Bristol-Myers Squibb (BMY) for the discovery and development of novel antibody drug conjugates using Ambrx's protein medicinal chem...
Biopharmaceuticals
Ambrx, Bristol-Myers Squibb

Sonatherm is the Only Laparoscopic HIFU Device Cleared for Ablating Soft Tissue in the U.S. CHARLOTTE, N.C., May 2, 2013 -- (Healthcare Sales & Marketing Network) -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HI...
Devices, Oncology, Urology, Product Launch
SonaCare Medical, Sonatherm, HIFU, Surgical Ablation, prostate cancer

GARDEN CITY, N.Y., May 2, 2013 -- (Healthcare Sales & Marketing Network) -- Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an agreement with Atossa Genetics Inc. (ATOS) for the distribution of Atossa'...
Devices, Diagnostics, Distribution
Millennium HealthCare, Atossa Genetics, ForeCYTE, Breast Health Test

CHARLOTTE, N.C.--(Healthcare Sales & Marketing Network)--The Premier healthcare alliance today announced new agreements for orthopedic power tools have been awarded to Brasseler USA of Savannah, Ga.; ConMed Linvatec of Largo, Fla.; and Stryker Sales Corpor...
Devices, Orthopaedic, Group Purchasing
Premier healthcare alliance, Brasseler, ConMed Linvatec, Stryker

Publication of PRECISE Trial Results in The Journal of American College of Cardiology builds on momentum of FDA clearance and commercialization of the CorPath® System WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--Corindus Vascular Robotics...
Devices, Interventional Cardiology
Corindus Vascular Robotics, CorPath, coronary angioplasty, robotic angioplasty

SOUTH SAN FRANCISCO, Calif., May 2, 2013 -- (Healthcare Sales & Marketing Network) -- Hyperion Therapeutics, Inc. (HPTX) today announced the exercise of its option to acquire BUPHENYL(R)(sodium phenylbutyrate) Tablets and Powder, an FDA approved therapy fo...
Biopharmaceuticals, Acquisitions
Hyperion Therapeutics, Valeant Pharmaceuticals, BUPHENYL, AMMONUL

Barry D. Quart, Pharm.D. Appointed Chief Executive Officer Robert Rosen Appointed President Steve Davis Appointed Chief Operating Officer REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--A.P. Pharma, Inc. (OTCBB:APPA.OB), a specialty ...
Biopharmaceuticals, Drug Delivery, Personnel
A.P. Pharma, Biochronomer, APF530

The Center for Wound Healing, Inc. has changed its name to RestorixHealth, giving further distinction to their expertise in developing and managing comprehensive wound care centers of excellence Tarrytown, NY--(Healthcare Sales & Marketing Network)--The...
Devices, Wound Care
RestorixHealth, Center for Wound Healing, hyperbaric oxygen

New Research Presented at Symposium on Advanced Wound Care and Wound Healing Society Shows Improved Patient Outcomes and Significant Cost Savings NASHVILLE, TN--(Healthcare Sales & Marketing Network) - Four studies presented at the Symposium on Advance...
Devices, Monitoring, Wound Care
Wellsense, Pressure Ulcer, bedside pressure mapping

NOVATO, Calif., May 1, 2013 -- (Healthcare Sales & Marketing Network) -- Ultragenyx Pharmaceutical Inc., a biotechnology company focused on the development of treatments for rare and ultra-rare genetic disorders, today announced it has appointed Eric Yuen,...
Biopharmaceuticals, Personnel
Ultragenyx Pharmaceutical

PARSIPPANY, N.J., and MONTREAL, May 1, 2013 -- (Healthcare Sales & Marketing Network) -- Actavis, Inc. (ACT), and Valeant Pharmaceuticals International, Inc. (VRX) (VRX) today announced that Actavis Specialty Brands (the "Company") has acquired ...
Biopharmaceuticals, Acquisitions
Valeant Pharmaceuticals, Actavis, Metronidazole

LAKE OSWEGO, Ore., May 1, 2013 -- (Healthcare Sales & Marketing Network) -- Galena Biopharma (GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announ...
Biopharmaceuticals, Oncology, Personnel
Galena Biopharma

SAN ANTONIO, May 1, 2013 -- (Healthcare Sales & Marketing Network) -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is among the first...
Devices, FDA
BiO2 Medical, Angel Catheter, Vena Cava Filter, Central Venous Catheter

First Guidelines to Incorporate Anti-Obesity Medications as Recommended Treatment for Cardiometabolic Diseases MOUNTAIN VIEW, Calif., May 1, 2013 -- (Healthcare Sales & Marketing Network) -- A new comprehensive treatment algorithm for diabetes from the ...
Biopharmaceuticals, Endocrinology
VIVUS, Qsymia, obesity

Dynavax Meeting With FDA Scheduled First Half of June BERKELEY, CA--(Healthcare Sales & Marketing Network) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the Company's board of directors has appointed Eddie Gray chief executive o...
Biopharmaceuticals, Personnel
Dynavax Technologies, HEPLISAV, hepatitis B vaccine